CSF1R | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

12 November 2024

Merck KGaA gets a rare cancer win

Regulatory

15 August 2024

Front-line setting next for axatilimab

Data insights Regulatory

8 August 2024

The month ahead: August’s remaining events

Following its odronextamab knockback, Regeneron now faces a delay to linvoseltamab.

Deals

29 April 2024

Ono goes for growth with $2.4bn Deciphera buy

Conferences Trial results

10 December 2023

ASH 2023 – Incyte hopes to add axatilimab to the arsenal

Deals

4 December 2023

Merck KGaA buys into a race with Deciphera

Regulatory Trial results

30 October 2023

Deciphera sets sights on a second marketed drug

Subscribe to CSF1R